{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:29:16Z","timestamp":1790648956675,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ypmed.2020.106190","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:17:21Z","timestamp":1593724641000},"page":"106190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Biopsychosocial mechanisms associated with tobacco use in smokers with and without serious mental illness"],"prefix":"10.1016","volume":"140","author":[{"given":"Teresa","family":"DeAtley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Denlinger-Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cioe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Donny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Tidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ypmed.2020.106190_bb0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ntr\/ntu163","article-title":"Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls","volume":"17","author":"AhnAllen","year":"2015","journal-title":"Nicotine Tob. Res."},{"issue":"10037","key":"10.1016\/j.ypmed.2020.106190_bb0010","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2020.106190_bb0015","article-title":"Biochemical verification of tobacco use and abstinence: 2019 update","author":"Benowitz","year":"2019","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.ypmed.2020.106190_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychol. Addict. Behav."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2013.09.014","article-title":"Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression","volume":"48","author":"Callaghan","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ypmed.2020.106190_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106190_bb0035","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/schbul\/sbv122","article-title":"Responses to tobacco smoking-related health messages in young people with recent-onset schizophrenia","volume":"41","author":"Coletti","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ypmed.2020.106190_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","article-title":"Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings","volume":"3","author":"Cox","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ypmed.2020.106190_bb0045","article-title":"Adolescent menthol cigarette use and risk of nicotine dependence: findings from the national Population Assessment on Tobacco and Health (PATH) study","volume":"206","author":"Cwalina","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2020.106190_bb0050","series-title":"Psychometric analysis of an environmental tobacco smoke questionnaire","author":"DeAtley","year":"2020"},{"issue":"14","key":"10.1016\/j.ypmed.2020.106190_bb0055","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMsa1502403","article-title":"Randomized trial of reduced-nicotine standards for cigarettes","volume":"373","author":"Donny","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2020.106190_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.irn.2015.08.001","article-title":"Effective cessation strategies for smokers with schizophrenia","volume":"124","author":"Evins","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106190_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/JCP.0000000000001015","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES trial","volume":"39","author":"Evins","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ntr\/ntr137","article-title":"Determinants of tobacco use and renaming the FTND to the Fagerstr\u00f6m Test for Cigarette Dependence","volume":"14","author":"Fagerstr\u00f6m","year":"2012","journal-title":"Nicotine Tob. Res."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106190_bb0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.biopsych.2013.03.017","article-title":"A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia","volume":"74","author":"Hahn","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ypmed.2020.106190_bb0080","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1378\/chest.128.4.2528","article-title":"Effects of cigarette reduction on cardiovascular risk factors and subjective measures","volume":"128","author":"Hatsukami","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ypmed.2020.106190_bb0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ntr\/ntv200","article-title":"Perceived health risks of snus and medicinal nicotine products","volume":"18","author":"Hatsukami","year":"2016","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ypmed.2020.106190_bb0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106190_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.ypmed.2020.106190_bb0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s11606-019-04857-3","article-title":"Cigarette smoking and quitting-related factors among US adult health center patients with serious mental illness","volume":"34","author":"Kalkhoran","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15504263.2016.1260190","article-title":"Predictors of the perception of smoking health risks in smokers with or without schizophrenia","volume":"13","author":"Kowalczyk","year":"2017","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.ypmed.2020.106190_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3389\/fpsyt.2018.00565","article-title":"A systematic review of psychosocial barriers and facilitators to smoking cessation in people living with schizophrenia","volume":"9","author":"Lum","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"18","key":"10.1016\/j.ypmed.2020.106190_bb0115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.15585\/mmwr.mm6718a3","article-title":"Tobacco cessation interventions and smoke-free policies in mental health and substance abuse treatment facilities - United States, 2016","volume":"67","author":"Marynak","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.ypmed.2020.106190_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.envres.2004.02.005","article-title":"A questionnaire for assessing environmental tobacco smoke exposure","volume":"97","author":"Nondahl","year":"2005","journal-title":"Environ. Res."},{"issue":"12","key":"10.1016\/j.ypmed.2020.106190_bb0125","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ypmed.2020.106190_bb0135","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14622200802097563","article-title":"Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM)","volume":"10","author":"Piper","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.ypmed.2020.106190_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1037\/a0018065","article-title":"Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation","volume":"78","author":"Piper","year":"2010","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.ypmed.2020.106190_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-publhealth-031816-044618","article-title":"Smoking, mental illness, and public health","volume":"38","author":"Prochaska","year":"2017","journal-title":"Annu. Rev. Public Health"},{"issue":"5","key":"10.1016\/j.ypmed.2020.106190_bb0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ntr\/nty241","article-title":"The 2016 Tips From Former Smokers\u00ae Campaign: associations with quit intentions and quit attempts among smokers with and without mental health conditions","volume":"21","author":"Prochaska","year":"2019","journal-title":"Nicotine Tob. Res."},{"issue":"11","key":"10.1016\/j.ypmed.2020.106190_bb0155","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ntr\/nty123","article-title":"Considering systemic barriers to treating tobacco use in clinical settings in the United States","volume":"21","author":"Rojewski","year":"2019","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106190_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2307\/2344953","article-title":"The classification of smoking by factorial structure of motives","volume":"137","author":"Russell","year":"1974","journal-title":"Journal of the Royal Statistical Society. Series A (General)"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106190_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yrtph.2006.09.001","article-title":"Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany","volume":"47","author":"Scherer","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106190_bb0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamapsychiatry.2015.2688","article-title":"Association of mental disorders with subsequent chronic physical conditions: World Mental Health Surveys from 17 countries","volume":"73","author":"Scott","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.ypmed.2020.106190_bb0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ntr\/ntq032","article-title":"Development of the Brief Wisconsin Inventory of Smoking Dependence Motives","volume":"12","author":"Smith","year":"2010","journal-title":"Nicotine Tob. Res."},{"issue":"e2","key":"10.1016\/j.ypmed.2020.106190_bb0180","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1136\/tobaccocontrol-2013-051466","article-title":"Smoking and mental illness in the U.S. population","volume":"23","author":"Smith","year":"2014","journal-title":"Tob. Control."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/tobaccocontrol-2018-054268","article-title":"Cigarette smoking among those with mental disorders in the US population: 2012\u20132013 update","volume":"29","author":"Smith","year":"2020","journal-title":"Tob. Control."},{"issue":"2\u20133","key":"10.1016\/j.ypmed.2020.106190_bb0190","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.schres.2009.09.032","article-title":"Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls","volume":"115","author":"Tidey","year":"2009","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106190_bb0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2005.04.002","article-title":"Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls","volume":"80","author":"Tidey","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106190_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ntr\/ntt152","article-title":"Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia","volume":"16","author":"Tidey","year":"2014","journal-title":"Nicotine Tob. Res."},{"issue":"Supplement 1","key":"10.1016\/j.ypmed.2020.106190_bb0205","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/ntr\/ntz133","article-title":"Effects of 6-week use of very low nicotine content cigarettes in smokers with serious mental illness","volume":"21","author":"Tidey","year":"2019","journal-title":"Nicotine & Tobacco Research"},{"issue":"11","key":"10.1016\/j.ypmed.2020.106190_bb0210","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1360-0443.1991.tb01732.x","article-title":"The development and initial validation of a questionnaire on smoking urges","volume":"86","author":"Tiffany","year":"1991","journal-title":"Br. J. Addict."},{"issue":"1","key":"10.1016\/j.ypmed.2020.106190_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ntr\/ntw183","article-title":"Barriers and facilitators to smoking cessation among people with severe mental illness: a critical appraisal of qualitative studies","volume":"19","author":"Trainor","year":"2017","journal-title":"Nicotine Tob. Res."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106190_bb0220","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J. Pers. Soc. Psychol."},{"issue":"2\u20133","key":"10.1016\/j.ypmed.2020.106190_bb0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2006.06.005","article-title":"Reliability of the Fagerstr\u00f6m Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia","volume":"86","author":"Weinberger","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"2\u20133","key":"10.1016\/j.ypmed.2020.106190_bb0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.drugalcdep.2011.04.009","article-title":"Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia","volume":"118","author":"Williams","year":"2011","journal-title":"Drug Alcohol Depend."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520302140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520302140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:09:26Z","timestamp":1758794966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743520302140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":46,"alternative-id":["S0091743520302140"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106190","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopsychosocial mechanisms associated with tobacco use in smokers with and without serious mental illness","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106190"}}